HealthCare Global Enterprises has completed the sale of its entire stake in BACC Health Care Private Limited to Inviga Healthcare Fund I for ₹37.64 crore. The company received ₹28.23 crore upfront, with the remainder as deferred payment.
HealthCare Global Enterprises Divests Subsidiary for ₹37.64 Crore
Total Consideration: ₹37.64 crore
Initial Consideration Received: ₹28.23 crore
Reader Takeaway: Strategic divestment completed; upfront cash bolsters liquidity; deferred payment is non-contingent.
What just happened
HealthCare Global Enterprises Limited has finalized the sale of its entire 99.999% stake in its subsidiary, BACC Health Care Private Limited, to Inviga Healthcare Fund I. The transaction was completed on June 29, 2026, following a Share Purchase Agreement signed on May 19, 2026.
Why this matters
This divestment aligns with the company's previously communicated strategic plan. It allows HealthCare Global to exit the subsidiary, realizing cash proceeds that can improve its liquidity. Investors gain clarity on the planned exit and the payment structure.
The backstory
The company had signed an agreement to sell its stake in BACC Health Care Private Limited. The transfer of shares has now been successfully executed.
What changes now
HealthCare Global Enterprises will no longer hold any significant stake in BACC Health Care Private Limited. The company will receive the remaining deferred payment over the next 18 months.
Risks to watch
The primary risk, non-receipt of deferred payment, is mitigated as the company stated it is time-deferred and not conditional or contingent.
Peer comparison
Information not available in the filing.
Context metrics (time-bound)
- Transaction Date: June 29, 2026
- Agreement Signing Date: May 19, 2026
- Deferred Payment Due: Within 18 months from May 19, 2026
What to track next
Investors should track the receipt of the deferred consideration and how HealthCare Global Enterprises utilizes the enhanced liquidity from this sale.